PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 120 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286 | -53.5% | 129,524 | -46.5% | 0.00% | -100.0% |
| Q1 2023 | $615 | +35.2% | 242,124 | -0.6% | 0.00% | 0.0% |
| Q4 2022 | $455 | -99.9% | 243,524 | +6.4% | 0.00% | 0.0% |
| Q3 2022 | $588,000 | +2.6% | 228,824 | -22.9% | 0.00% | 0.0% |
| Q2 2022 | $573,000 | +11.3% | 296,676 | +71.1% | 0.00% | 0.0% |
| Q1 2022 | $515,000 | +197.7% | 173,424 | +349.0% | 0.00% | – |
| Q4 2021 | $173,000 | -82.3% | 38,624 | -80.8% | 0.00% | -100.0% |
| Q3 2021 | $980,000 | -66.5% | 201,624 | -52.9% | 0.00% | -75.0% |
| Q2 2021 | $2,922,000 | -31.5% | 428,424 | -29.0% | 0.00% | -20.0% |
| Q1 2021 | $4,263,000 | -10.5% | 603,820 | -20.7% | 0.01% | 0.0% |
| Q4 2020 | $4,765,000 | +62.7% | 761,220 | +40.6% | 0.01% | +66.7% |
| Q3 2020 | $2,929,000 | +19.3% | 541,420 | +15.1% | 0.00% | +50.0% |
| Q2 2020 | $2,456,000 | +392.2% | 470,508 | +276.0% | 0.00% | – |
| Q2 2019 | $499,000 | -67.7% | 125,149 | -56.5% | 0.00% | -100.0% |
| Q1 2019 | $1,543,000 | -13.1% | 287,849 | -16.8% | 0.00% | -50.0% |
| Q4 2018 | $1,776,000 | -15.5% | 346,170 | +59.6% | 0.00% | 0.0% |
| Q3 2018 | $2,103,000 | -83.7% | 216,849 | -80.5% | 0.00% | -71.4% |
| Q2 2018 | $12,928,000 | +74.2% | 1,110,798 | +94.6% | 0.01% | -12.5% |
| Q1 2018 | $7,421,000 | -8.0% | 570,849 | +26.7% | 0.01% | -11.1% |
| Q4 2017 | $8,067,000 | -13.3% | 450,649 | +21.6% | 0.01% | -18.2% |
| Q3 2017 | $9,306,000 | -35.3% | 370,738 | -37.9% | 0.01% | -38.9% |
| Q2 2017 | $14,382,000 | +80.2% | 596,749 | +44.0% | 0.02% | +63.6% |
| Q1 2017 | $7,979,000 | +369.9% | 414,513 | +275.9% | 0.01% | +266.7% |
| Q4 2016 | $1,698,000 | -9.1% | 110,264 | -23.2% | 0.00% | 0.0% |
| Q3 2016 | $1,867,000 | +31.3% | 143,513 | +40.3% | 0.00% | 0.0% |
| Q2 2016 | $1,422,000 | +19.3% | 102,264 | +30.2% | 0.00% | +50.0% |
| Q1 2016 | $1,192,000 | -25.0% | 78,564 | -6.3% | 0.00% | -33.3% |
| Q4 2015 | $1,590,000 | -15.3% | 83,813 | -15.2% | 0.00% | -25.0% |
| Q3 2015 | $1,877,000 | -30.0% | 98,813 | -5.1% | 0.00% | -33.3% |
| Q2 2015 | $2,682,000 | +117.3% | 104,086 | +163.7% | 0.01% | +100.0% |
| Q1 2015 | $1,234,000 | +37.0% | 39,464 | +68.9% | 0.00% | +50.0% |
| Q4 2014 | $901,000 | – | 23,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,387,172 | $6,537,000 | 1.72% |
| Worth Venture Partners, LLC | 969,698 | $2,366,000 | 1.39% |
| Omega Fund Management, LLC | 1,971,241 | $3,804,000 | 1.21% |
| Telemetry Investments, L.L.C. | 495,000 | $955,000 | 1.13% |
| CM Management, LLC | 350,000 | $676,000 | 0.72% |
| Bruce & Co., Inc. | 1,557,312 | $3,005,000 | 0.71% |
| Trellus Management Company, LLC | 295,000 | $569,000 | 0.69% |
| Abingworth LLP | 1,041,131 | $1,999,000 | 0.64% |
| 1492 Capital Management LLC | 489,376 | $944,000 | 0.62% |
| GENERAL AMERICAN INVESTORS CO INC | 1,752,470 | $3,382,000 | 0.34% |